Core Viewpoint - A class action lawsuit has been filed against Quantum Biopharma Ltd. for alleged securities fraud and unlawful business practices, with a deadline for investors to join the lawsuit by February 23, 2026 [1]. Group 1: Lawsuit Details - The lawsuit claims that Quantum and certain officers and/or directors engaged in securities fraud [1]. - Defendants, including CIBC World Markets and Royal Bank of Canada, are accused of placing thousands of spoofed sell orders to create a false impression of Quantum's stock price decline [1]. - These manipulative orders allegedly deceived investors into selling their shares at artificially low prices, allowing the Defendants to purchase shares at depressed levels for profit [1]. Group 2: Legal Representation - Pomerantz LLP, a prominent law firm specializing in corporate and securities class litigation, is representing the affected investors [1]. - The firm has a long history of fighting for victims of securities fraud and has recovered numerous multimillion-dollar damages awards [1].